[1]高 珊,乔 媛,董春萍.2型糖尿病视网膜病变患者血清Notch1、Notch3和JAG1水平变化及检测意义[J].陕西医学杂志,2025,54(5):688-692.[doi:DOI:10.3969/j.issn.1000-7377.2025.05.023]
 GAO Shan,QIAO Yuan,DONG Chunping.Changes and detection significance of serum Notch1,Notch3 and JAG1 levels in patients with type 2 diabetic retinopathy[J].,2025,54(5):688-692.[doi:DOI:10.3969/j.issn.1000-7377.2025.05.023]
点击复制

2型糖尿病视网膜病变患者血清Notch1、Notch3和JAG1水平变化及检测意义
分享到:

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
54
期数:
2025年5期
页码:
688-692
栏目:
临床检验
出版日期:
2025-05-05

文章信息/Info

Title:
Changes and detection significance of serum Notch1,Notch3 and JAG1 levels in patients with type 2 diabetic retinopathy
作者:
高 珊乔 媛董春萍
(陕西省人民医院内分泌科,陕西 西安 710068)
Author(s):
GAO ShanQIAO YuanDONG Chunping
(Department of Endocrinology,Shaanxi Provincial People's Hospital,Xi'an 710068,China)
关键词:
2型糖尿病 糖尿病视网膜病变 Notch1 Notch3 JAG1 预测价值
Keywords:
Type 2 diabetes mellitus Diabetic retinopathy Notch1 Notch3 JAG1 Predictive value
分类号:
R 587.1
DOI:
DOI:10.3969/j.issn.1000-7377.2025.05.023
文献标志码:
A
摘要:
目的:探讨2型糖尿病视网膜病变(DR)患者血清Notch1、Notch3和JAG1水平变化及检测意义。方法:选取2型糖尿病(T2DM)患者147例,根据有无并发DR将患者分为病变组(45例)和未病变组(102例)。收集两组患者临床资料,采用实时荧光定量PCR(RT-qPCR)检测血清Notch1、Notch3和JAG1表达水平。采用Spearman法分析血清Notch1、Notch3和JAG1表达水平与T2DM患者并发DR的相关性。绘制受试者工作特征(ROC)曲线分析血清Notch1、Notch3和JAG1对T2DM患者并发DR的预测价值。采用多因素Logistic回归模型分析T2DM患者并发DR的影响因素。结果:病变组患者T2DM病程、糖化血红蛋白(HbAlc)水平高于未病变组(均P<0.05)。与未病变组比较,病变组患者血清Notch1、Notch3和JAG1表达水平降低(均P<0.05)。血清Notch1、Notch3和JAG1表达水平与T2DM患者并发DR呈负相关(均P<0.05)。血清Notch1、Notch3和JAG1联合预测T2DM患者并发DR的曲线下面积(AUC)为0.905高于三者单独预测的AUC(均P<0.05)。T2DM病程、HbAlc、血清Notch1、Notch3和JAG1为T2DM患者并发DR的独立影响因素(均P<0.05)。结论:T2DM并发DR患者血清Notch1、Notch3和JAG1表达水平降低,对T2DM患者并发DR有一定预测价值,且三者联合预测的效能更高。
Abstract:
Objective:To investigate the changes in serum Notch1,Notch3 and JAG1 levels and the significance of detection in patients with type 2 diabetic retinopathy(DR).Methods:A total of 147 patients with type 2 diabetes mellitus(T2DM)were selected and divided into two groups:the DR group(45 cases)and the non-DR group(102 cases).Clinical data were collected from both groups.The expression levels of serum Notch1,Notch3 and JAG1 were detected using real-time quantitative PCR(RT-qPCR).Spearman correlation analysis was used to evaluate the correlation between the expression levels of serum Notch1,Notch3 and JAG1 and the occurrence of DR in T2DM patients.Receiver operating characteristic(ROC)curves were plotted to analyze the predictive value of serum Notch1,Notch3 and JAG1 for DR in T2DM patients.Multivariate logistic regression analysis was performed to identify the influencing factors of DR in T2DM patients.Results:The duration of T2DM and the level of HbA1c were higher in the DR group than in the non-DR group(all P<0.05).Compared with the non-DR group,the expression levels of serum Notch1,Notch3 and JAG1 were significantly lower in the DR group(all P<0.05).The expression levels of serum Notch1,Notch3 and JAG1 were negatively correlated with the occurrence of DR in T2DM patients(all P<0.05).The AUC for the combined prediction of DR by serum Notch1,Notch3 and JAG1 was 0.905,which was higher than that of individual predictions(all P<0.05).The duration of T2DM,HbA1c and serum levels of Notch1,Notch3 and JAG1 were identified as independent influencing factors for DR in T2DM patients(all P<0.05).Conclusion:The expression levels of serum Notch1,Notch3 and JAG1 are decreased in T2DM patients with DR,and they have predictive value for DR in T2DM patients.The combined prediction of these three markers provides higher efficacy.

参考文献/References:

[1] OLOKOBA A B,OBATERU O A,OLOKOBA L B.Type 2 diabetes mellitus:A review of current trends[J].Oman Med J,2012,27(4):269-273.
[2] 马晓军.外周血C肽、糖化血红蛋白和血糖水平与2型糖尿病患者并发症发生关系及其预测价值研究[J].陕西医学杂志,2023,52(9):1211-1213.
[3] NSIAH-KUMI P,ORTMEIER S R,BROWN A E.Disparities in diabetic retinopathy screening and disease for racial and ethnic minority populations-a literature review[J].J Natl Med Assoc,2009,101(5):430-437.
[4] TAJUNISAH I,WONG P,TAN L,et al.Awareness of eye complications and prevalence of retinopathy in the first visit to eye clinic among type 2 diabetic patients[J].Int J Ophthalmol,2011,4(5):519-524.
[5] WONG T Y,CHEUNG N,TAY W T,et al.Prevalence and risk factors for diabetic retinopathy:The Singapore Malay eye study[J].Ophthalmology,2008,115(11):1869-1875.
[6] XIE H,SUN J,CHEN Y,et al.EGCG attenuates uric acid-induced inflammatory and oxidative stress responses by medicating the NOTCH pathway[J].Oxid Med Cell Longev,2015,2015:214836.
[7] BRAY S J.Notch signaling:A simple pathway becomes complex[J].Nat Rev Mol Cell Biol,2006,7(9):678-689.
[8] DOU G R,WANG L,WANG Y S,et al.Notch signaling in ocular vasculature development and diseases[J].Mol Med,2012,18(1):47-55.
[9] MILOUDI K,OUBAHA M,MÉNARD C,et al.NOTCH1 signaling induces pathological vascular permeability in diabetic retinopathy[J].Proc Natl Acad Sci U S A,2019,116(10):4538-4547.
[10] HAM S W,KIM J Y,SEO S,et al.Annexin A2 stabilizes oncogenic JAG1 intracellular domain by inhibiting proteasomal degradation in glioblastoma cells[J].Int J Mol Sci,2023,24(19):14776.
[11] JIANG H,ZHOU C,ZHANG Z,et al.Jagged1-Notch1-deployed tumor perivascular niche promotes breast cancer stem cell phenotype through Zeb1[J].Nat Commun,2020,11(1):5129.
[12] CHEEMA M R,STONE L G,SELLAR P W,et al.Long-term follow-up of a patient with JAG1-associated retinopathy[J].Doc Ophthalmol,2021,143(2):237-247.
[13] GENUTH S,ALBERTI K G,BENNETT P,et al.Follow-up report on the diagnosis of diabetes mellitus[J].Diabetes Care,2003,26(11):3160-3167.
[14] CHO N H,SHAW J E,KARURANGA S,et al.IDF diabetes atlas:Global estimates of diabetes prevalence for 2017 and projections for 2045[J].Diabetes Res Clin Pract,2018,138:271-281.
[15] CHEUNG N,MITCHELL P,WONG T Y.Diabetic retinopathy[J].Lancet,2010,376(9735):124-136.
[16] 张琳钧,冯学祯.理气化瘀清肝明目方治疗糖尿病性视网膜病变疗效观察[J].陕西中医,2014,35(4):452-453.
[17] 白淑玮,毕春潮,邵娟,等.玻璃体切割手术联合全视网膜光凝术治疗糖尿病视网膜病变临床疗效观察[J].陕西医学杂志,2020,49(12):1569-1572.
[18] TING D S,CHEUNG G C,WONG T Y.Diabetic retinopathy:Global prevalence,major risk factors,screening practices and public health challenges:A review[J].Clin Exp Ophthalmol,2016,44(4):260-277.
[19] TEO Z L,THAM Y C,YU M,et al.Global prevalence of diabetic retinopathy and projection of burden through 2045:Systematic review and meta-analysis[J].Ophthalmology,2021,128(11):1580-1591.
[20] CHEUNG N,WONG T Y.Diabetic retinopathy and systemic vascular complications[J].Prog Retin Eye Res,2008,27(2):161-176.
[21] DRINKWATER J J,DAVIS T,HELLBUSCH V,et al.Retinopathy predicts stroke but not myocardial infarction in type 2 diabetes:The fremantle diabetes study phase Ⅱ[J].Cardiovasc Diabetol,2020,19(1):43.
[22] NANEGRUNGSUNK O,PATIKULSILA D,SADDA S R.Ophthalmic imaging in diabetic retinopathy:A review[J].Clin Exp Ophthalmol,2022,50(9):1082-1096.
[23] ANG M J,AFSHARI N A.Cataract and systemic disease:A review[J].Clin Exp Ophthalmol,2021,49(2):118-127.
[24] CERANI A,TETREAULT N,MENARD C,et al.Neuron-derived semaphorin 3A is an early inducer of vascular permeability in diabetic retinopathy via neuropilin-1[J].Cell Metab,2013,18(4):505-518.
[25] DOU G R,WANG Y C,HU X B,et al.RBP-J,the transcription factor downstream of Notch receptors,is essential for the maintenance of vascular homeostasis in adult mice[J].FASEB J,2008,22(5):1606-1617.
[26] 孙立平,周霞,刘炬,等.从调控血管内皮生长因子及其受体激活Notch信号通路角度探讨生地梓醇促血管新生及神经功能重塑作用[J].实用心脑肺血管病杂志,2021,29(11):63-68.
[27] ROSTAMA B,PETERSON S M,VARY C P,et al.Notch signal integration in the vasculature during remodeling[J].Vascul Pharmacol,2014,63(2):97-104.
[28] TEFFT J B,BAYS J L,LAMMERS A,et al.Notch1 and Notch3 coordinate for pericyte-induced stabilization of vasculature[J].Am J Physiol Cell Physiol,2022,322(2):C185-C196.
[29] XIU M X,LIU Y M,KUANG B H.The oncogenic role of Jagged1/Notch signaling in cancer[J].Biomed Pharmacother,2020,129:110416.
[30] ZHANG L,ZHANG X,XU H,et al.Exome sequencing revealed Notch ligand JAG1 as a novel candidate gene for familial exudative vitreoretinopathy[J].Genet Med,2020,22(1):77-84.
[31] 胡迭.Notch-1、D11-4在糖尿病大鼠早期视网膜病变中的作用[D].青岛:青岛大学,2015.
[32] 秦秀虹,张珍珍,许海涛,等.Notch1和多聚二磷酸腺苷核糖聚合酶-1在糖尿病小鼠视网膜中的表达[J].中华实验眼科杂志,2014,32(4):340-344.
[33] SRINIVASAN S,SIVAPRASAD S,RAJALAKSHMI R,et al.Early retinal functional alteration in relation to diabetes duration in patients with type 2 diabetes without diabetic retinopathy[J].Sci Rep,2022,12(1):11422.
[34] 中华医学会糖尿病学分会,中华医学会内分泌学分会.中国成人2型糖尿病患者糖化血红蛋白控制目标及达标策略专家共识[J].中华糖尿病杂志,2020,12(1):1-12.
[35] ZHU D D,WANG Y Z,ZOU C,et al.The role of uric acid in the pathogenesis of diabetic retinopathy based on Notch pathway[J].Biochem Biophys Res Commun,2018,503(2):921-929.

相似文献/References:

[1]李艳艳,贾 伟△.24h动态心电图在2型糖尿病合并冠心病患者心律诊断中的价值分析[J].陕西医学杂志,2019,(1):61.
[2]郭向东,马 波△.2型糖尿病患者血清胰岛素水平与骨代谢关联研究*[J].陕西医学杂志,2019,(1):77.
 GUO Xiangdong,MA Bo..Association between serum insulin level and bone metabolismin patients with type 2 diabetes mellitus[J].,2019,(5):77.
[3]刘毅龙,陈鹏宇,雷 江,等.SGLT2抑制剂在2型糖尿病合并心血管疾病治疗中的应用研究进展[J].陕西医学杂志,2019,(3):407.
[4]姚爱红.利拉鲁肽治疗2型糖尿病效果及对患者血脂、颈动脉内膜中层厚度的影响[J].陕西医学杂志,2019,(4):518.
 YAO Aihong..Effect of liraglutide on type 2 diabetes mellitus in patients with blood lipids and carotid intimamedia thickness[J].,2019,(5):518.
[5]李忆琴,吴礼凤,余晓君,等.中年2型糖尿病患者病程和HbA1c水平与认知功能相关性研究*[J].陕西医学杂志,2019,(6):722.
[6]徐 琳,贾睿博△,宋民喜,等.颗粒蛋白前体与糖尿病肾病关系探讨*[J].陕西医学杂志,2019,(8):1024.
[7]王荣锋,郁 昊,蒋新建.老年糖尿病患者血清25羟维生素D水平与骨质疏松相关性研究[J].陕西医学杂志,2019,(8):1032.
 WANG Rongfeng,YU Hao,JIANG Xinjian..The relationship between serum 25 hydroxy vitamin D and osteoporosis in elderly diabetic patients[J].,2019,(5):1032.
[8]王 荣,贾爱华,刘新艳 ,等.IGF1及其相关性因素对2型糖尿病并发骨质疏松的影响研究[J].陕西医学杂志,2019,(9):1163.
 WANG Rong,JIA Aihua,LIU Xinyan,et al.The effect of IGF1 and its related factors in type 2 diabetes complicated with osteoporosis[J].,2019,(5):1163.
[9]贾睿博,徐 琳△.2型糖尿病患者下肢血管病变相关危险因素调查研究[J].陕西医学杂志,2019,(11):1567.
[10]郭建强,赵俊宏,张分队,等.2型糖尿病视网膜病变患者血清HbA1c、CysC检测及临床意义*[J].陕西医学杂志,2020,49(5):619.
 GUO Jianqiang,ZHAO Junhong,ZHANG Fendui,et al.Changes of serum HbA1c and CysC in patients with type 2 diabetic retinopathy and their clinical significance[J].,2020,49(5):619.

备注/Memo

备注/Memo:
[基金项目]陕西省重点研发计划项目(2019SF-971)
更新日期/Last Update: 2025-05-05